Evidence map›Paper›PMID 33972655›Full record

ArticleScientific reports2021

Use of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs.

Pan P Li, Russell L Margolis

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Efficient gene editing through an intronic selection marker in cells.Cellular and molecular life sciences : CMLS · 2022
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pan P LiDepartment of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, CMSC 8-121, 600 N. Wolfe St, Baltimore, MD, 21287, USA. ple5@jhmi.edu.
Russell L MargolisDepartment of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, CMSC 8-121, 600 N. Wolfe St, Baltimore, MD, 21287, USA.
Johns Hopkins University · US

Funding

Endogenous regulation of huntingtin expression as a therapeutic target for Huntington's diseaseR01NS100783 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MARGOLIS, RUSSELL L · 2017 to 2021
$2.4M
Evaluation of the role of RNA toxicity in SCA2 pathogenesis using genome editing in patient iPSCsR21NS112796 · NINDS · JOHNS HOPKINS UNIVERSITY · PI ELLERBY, LISA M, LI, PAN · 2019 to 2019
$506k
Novel knock-in mouse models of spinocerebellar ataxia type 12R21NS112687 · NINDS · JOHNS HOPKINS UNIVERSITY · PI LI, PAN · 2020 to 2020
$450k
NINDS NIH HHS NS100783NINDS NIH HHS NS112687NINDS NIH HHS R01 NS100783NINDS NIH HHS R21 NS112687NINDS NIH HHS R21 NS112796
6 · The paper itself

Abstract

Cas9 nucleases permit rapid and efficient generation of gene-edited cell lines. However, in typical protocols, mutations are intentionally introduced into the donor template to avoid the cleavage of donor template or re-cleavage of the successfully edited allele, compromising the fidelity of the isogenic lines generated. In addition, the double-stranded breaks (DSBs) used for editing can introduce undesirable "on-target" indels within the second allele of successfully modified cells via non-homologous end joining (NHEJ). To address these problems, we present an optimized protocol for precise genome editing in human iPSCs that employs (1) single guided Cas9 nickase to generate single-stranded breaks (SSBs), (2) transient overexpression of BCL-XL to enhance survival post electroporation, and (3) the PiggyBac transposon system for seamless removal of dual selection markers. We have used this method to modify the length of the CAG repeat contained in exon 7 of PPP2R2B. When longer than 43 triplets, this repeat causes the neurodegenerative disorder spinocerebellar ataxia type 12 (SCA12); our goal was to seamlessly introduce the SCA12 mutation into a human control iPSC line. With our protocol, ~ 15% of iPSC clones selected had the desired gene editing without "on target" indels or off-target changes, and without the deliberate introduction of mutations via the donor template. This method will allow for the precise and efficient editing of human iPSCs for disease modeling and other purposes.

Indexed as

Cell LineCRISPR-Associated Protein 9CRISPR-Cas SystemsDeoxyribonuclease IDNA Breaks, Single-StrandedDNA End-Joining RepairElectroporationExonsGene EditingGenetic TherapyGenome, HumanHumansInduced Pluripotent Stem CellsKaryotypingMutationNerve Tissue ProteinsCRISPR-Associated Protein 9Deoxyribonuclease INerve Tissue ProteinsPPP2R2B protein, humanProtein Phosphatase 2RNA, Guide, CRISPR-Cas Systems

Identifiers

PMID33972655
PMCPMC8110799
OpenAlexW3160470277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.